SAN DIEGO , Jan. 30, 2023 (GLOBE NEWSWIRE) -- Exagen Inc. (Nasdaq: XGN), a leading provider of autoimmune testing solutions, today announced its participation in the BTIG MedTech, Digital Health , Life Science & Diagnostic Tools Conference , which takes place February 14-16, 2023 in Snowbird, UT .

SAN DIEGO , Jan. 23, 2023 (GLOBE NEWSWIRE) -- Exagen Inc. (Nasdaq: XGN), a leading provider of autoimmune testing solutions, announced today that Tina S. Nova , Ph.D. has been elected as Executive Chair of the Exagen Board of Directors, effective January 19, 2023 . Dr.